trending Market Intelligence /marketintelligence/en/news-insights/trending/bsbIQxReHkIanJ_7UMzQEg2 content esgSubNav
In This List

Alliance Pharma adds 2 directors

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises

Blog

Essential IR Insights Newsletter - Summer July-August 2023

Blog

Insight Weekly: Climate law faces hurdles; US borrowing surges; banks revise uninsured deposits


Alliance Pharma adds 2 directors

Alliance Pharma PLC has appointed Jo Le Couilliard and Richard Jones as nonexecutive directors to the board, effective Jan. 1, 2019.

Le Couilliard has served as a nonexecutive director of Circassia Pharmaceuticals PLC since Feb. 13. She was also senior vice president, global commercial transformation at GlaxoSmithKline PLC. In addition, she served as a nonexecutive director of the Frimley Park Hospital NHS Foundation Trust.

Jones is CFO of Mereo BioPharma Group PLC, a clinical-stage biopharmaceutical company. Previously, he was CFO of Shield Therapeutics PLC, a specialty pharmaceutical company.

Chippenham, U.K.-based Alliance Pharma operates as a specialty pharmaceutical company.